Company Profiles

driven by the PitchBook Platform

Lycera

Description

Developer of molecule therapies and drugs for the treatment of autoimmune diseases and cancer. The company engages in research and development of drugs for the treatment of diseases such as psoriasis, rheumatoid arthritis, lupus erythematosis, inflammatory bowel disease, cancer and other autoimmune disease.

2006

Founded

PRIVATE

Status

51-200

Employees

Series B

Latest Deal Type

$29.9M

Latest Deal Amount

$115M

Total Amount Raised

Description

Developer of molecule therapies and drugs for the treatment of autoimmune diseases and cancer. The company engages in research and development of drugs for the treatment of diseases such as psoriasis, rheumatoid arthritis, lupus erythematosis, inflammatory bowel disease, cancer and other autoimmune disease.

Website:

www.lycera.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

2800 Plymouth Road NCRC, Building 26 Ann Arbor, MI 48109United States +1 (734) 233-3060
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Lycera's full profile, request a free trial.

    Lycera Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Lycera Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Lycera Investors (6)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    ARCH Venture PartnersVenture CapitalMinority000 0000000 0000
    Clarus VenturesVenture CapitalMinority000 0000000 0000
    EDF VenturesVenture CapitalMinority000 0000000 0000
    InterWest Healthcare PartnersVenture CapitalMinority000 0000000 0000
    Michigan Investment in New Technology StartupsVenture CapitalMinority000 0000000 0000
    ARCH Venture Partners Venture Capital
    Clarus Ventures Venture Capital
    EDF Ventures Venture Capital
    InterWest Healthcare Partners Venture Capital
    Michigan Investment in New Technology Startups Venture Capital

    Lycera Executive Team (12)

    NameTitleBoard
    Seat
    Contact
    Info
    Paul SekhriPresident, Chief Executive Officer & Board Member
    Alex HowarthChief Financial Officer
    Bruce Goldsmith Ph.DChief Operating Officer and Chief Business Officer
    Laura CarterSenior Vice President, Biology
    Peter Toogood Ph.DSenior Vice President of Chemistry and Chemical Biology
    Paul Sekhri President, Chief Executive Officer & Board Member
    Alex Howarth Chief Financial Officer
    Bruce Goldsmith Ph.D Chief Operating Officer and Chief Business Officer
    Laura Carter Senior Vice President, Biology
    Peter Toogood Ph.D Senior Vice President of Chemistry and Chemical Biology

    Lycera Board Members (11)

    NameRepresentingRoleSinceContact
    Info
    Finny Kuruvilla Ph.DClarus VenturesPrincipal000 0000
    Jeffrey Leiden MDClarus VenturesSenior Advisor000 0000
    Kristina BurowARCH Venture PartnersManaging Director000 0000
    Mary CampbellEDF VenturesFounder & Managing Director000 0000
    Michael HaydenSelfBoard Member000 0000
    Finny Kuruvilla Ph.D Principal Clarus Ventures
    Jeffrey Leiden MD Senior Advisor Clarus Ventures
    Kristina Burow Managing Director ARCH Venture Partners
    Mary Campbell Founder & Managing Director EDF Ventures
    Michael Hayden Board Member Self
    Request full access to PitchBook